Focus:
Industry News
-
22 March 2019
UK MHRA recalls more batches of sartan medication
The UK Medicines and Healthcare Products Regulatory Agency has recalled three more batches of Losartan tablets amid fears of contamination with NMBA.
-
20 March 2019
AbbVie-Roche’s multiple myeloma trials halted by FDA
AbbVie has announced the US Food and Drug Administration (FDA) has placed a partial clinical hold on all clinical trials evaluating venetoclax for multiple myeloma.
-
20 March 2019
European pharma body warns of Brexit drug supply risk to EU
The European Federation of Pharmaceutical Industries and Associations (EFPIA) has raised concerns regarding the post-Brexit supply of medicines from the UK to the European Union (EU).
-
18 March 2019
NASA calls for new vaccinations to combat virus reactivation during spaceflight
Researchers from NASA’s Johnson Space Center have discovered that dormant herpes viruses reactivate during spaceflight, leading to an urgent need to develop counter-measures, including vaccination, to ensure the success of...
-
14 March 2019
Stanford researchers identify existing drug can mitigate chemotherapy side effects
Researchers from the Stanford University School of Medicine have discovered that AMPK activators, which include metformin for type 2 diabetes, could mitigate the cardiac side effects of chemotherapy drug trastuzumab.
-
13 March 2019
US Senate invites pharmacy benefit managers to testify on drug pricing
The US Senate Finance Committee has invited executives from five major pharmacy benefit managers to testify about the rising prescription medicine costs in the country.
-
13 March 2019
Brussels aims to attract UK pharma business post-Brexit
The Brussels Capital Region has launched a major campaign to attract UK-based pharmaceutical and life sciences sector after Brexit.
-
12 March 2019
UK prioritises transport of medical products in no-deal Brexit scenario
Despite continued attempts to reach a deal acceptable to Parliament in order for the UK to leave the European Union (EU) with a deal on 29 March, various UK Government...
-
11 March 2019
WHO launches its most far-reaching strategy against influenza globally
The World Health Organization (WHO) has launched its Global Influenza Strategy for 2019-2030, its most comprehensive strategy to date against the infectious disease.
-
11 March 2019
Takeda’s Entyvio achieves superior remission than Humira in ulcerative colitis
Takeda has announced results from Phase IIIb head-to-head study of two biologic therapies, Entyvio (vedolizumab) and adalimumab, the generic of AbbVie’s Humira, in which Entyvio achieved statistically significant clinical remission...